Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Adrenergic signaling in cardiomyocytes
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||
2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Adrenergic signaling in cardiomyocytes
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||
3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Adrenergic signaling in cardiomyocytes
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬3. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||
4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Adrenergic signaling in cardiomyocytes
| Digoxin | 008 [3] 8 , 46, 210 💬4. Adrenergic signaling in cardiomyocytes |
||||||||||||||||||||||||||||||||||||||||
5 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
AGTR1 [1] AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Valsartan Valsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬5. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||
6 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
AGTR1 [1] AGTR1 💬Aldosterone synthesis and secretion
|
Valsartan Valsartan 💬Aldosterone synthesis and secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬6. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||
7 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Aldosterone synthesis and secretion
| Digoxin | 008 [3] 8 , 46, 210 💬7. Aldosterone synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||
8 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 30 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Aldosterone-regulated sodium reabsorption
| Digoxin | 008 [3] 8 , 46, 210 💬8. Aldosterone-regulated sodium reabsorption |
||||||||||||||||||||||||||||||||||||||||
9 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 30 diseases |
NR3C2 [1] NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Eplerenone Eplerenone 💬Aldosterone-regulated sodium reabsorption
| Eplerenone | 075 [4] 75, 113, 210, 215 💬9. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||
10 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 30 diseases |
NR3C2 [1] NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Spironolactone Spironolactone 💬Aldosterone-regulated sodium reabsorption
| Spironolactone | 046 [8] 46, 58, 67, 86, 113, 210, 218, 225 💬10. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||
11 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
MME [1] MME 💬Alzheimer disease
|
Sacubitril Sacubitril 💬Alzheimer disease
| Sacubitril | 058 [3] 58, 210, 222 💬11. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||
12 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PTGS2 [1] PTGS2 💬Alzheimer disease
|
Aspirin Aspirin 💬Alzheimer disease
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬12. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||
13 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Alzheimer disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬13. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||
14 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
ADRA1A [1] ADRA1A 💬AMPK signaling pathway
|
Carvedilol Carvedilol 💬AMPK signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬14. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
15 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
ADRA1A [1] ADRA1A 💬AMPK signaling pathway
|
Carvedilol phosphate Carvedilol phosphate 💬AMPK signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬14. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
16 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pravastatin sodium Pravastatin sodium 💬AMPK signaling pathway
| Pravastatin | 013 [10] 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
17 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pravastatin Pravastatin 💬AMPK signaling pathway
| Pravastatin | 013 [10] 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
18 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Amyotrophic lateral sclerosis
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬18. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||
19 | Apelin signaling pathway 💬 20 genes, 36 drugs (DrugBank) and 77 diseases |
AGTR1 [1] AGTR1 💬Apelin signaling pathway
|
Valsartan Valsartan 💬Apelin signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬19. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
20 | Arachidonic acid metabolism 💬 5 genes, 25 drugs (DrugBank) and 44 diseases |
PTGS1 [2] PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Arachidonic acid metabolism
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬20. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||
21 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Bile secretion
| Digoxin | 008 [3] 8 , 46, 210 💬21. Bile secretion |
||||||||||||||||||||||||||||||||||||||||
22 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pravastatin sodium Pravastatin sodium 💬Bile secretion
| Pravastatin | 013 [10] 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||
23 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pravastatin Pravastatin 💬Bile secretion
| Pravastatin | 013 [10] 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||
24 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PTGS2 [1] PTGS2 💬C-type lectin receptor signaling pathway
|
Aspirin Aspirin 💬C-type lectin receptor signaling pathway
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬24. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
25 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Calcium signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
26 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Calcium signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
27 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AGTR1 [1] AGTR1 💬Calcium signaling pathway
|
Valsartan Valsartan 💬Calcium signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬27. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
28 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
AVPR1A [2] AVPR1A, AVPR1B 💬
|
Vasopressin Vasopressin 💬Calcium signaling pathway
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||
29 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [1] EDNRA 💬Calcium signaling pathway
|
Ambrisentan Ambrisentan 💬Calcium signaling pathway
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬29. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
30 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
31 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
32 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Calcium signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬32. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
33 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬cAMP signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬33. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
34 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬cAMP signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬33. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
35 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬cAMP signaling pathway
| Digoxin | 008 [3] 8 , 46, 210 💬35. cAMP signaling pathway |
||||||||||||||||||||||||||||||||||||||||
36 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Ambrisentan Ambrisentan 💬cAMP signaling pathway
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬36. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
37 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬37. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
38 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬37. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
39 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Macitentan Macitentan 💬cAMP signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬39. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
40 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Carbohydrate digestion and absorption
| Digoxin | 008 [3] 8 , 46, 210 💬40. Carbohydrate digestion and absorption |
||||||||||||||||||||||||||||||||||||||||
41 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Cardiac muscle contraction
| Digoxin | 008 [3] 8 , 46, 210 💬41. Cardiac muscle contraction |
||||||||||||||||||||||||||||||||||||||||
42 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬cGMP-PKG signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬42. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
43 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬cGMP-PKG signaling pathway
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬42. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
44 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
AGTR1 [1] AGTR1 💬cGMP-PKG signaling pathway
|
Valsartan Valsartan 💬cGMP-PKG signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬44. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
45 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬cGMP-PKG signaling pathway
| Digoxin | 008 [3] 8 , 46, 210 💬45. cGMP-PKG signaling pathway |
||||||||||||||||||||||||||||||||||||||||
46 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [1] EDNRA 💬cGMP-PKG signaling pathway
|
Ambrisentan Ambrisentan 💬cGMP-PKG signaling pathway
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬46. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
47 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬47. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
48 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬47. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
49 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬cGMP-PKG signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬49. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
50 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PDE5 [1] PDE5 💬cGMP-PKG signaling pathway
|
Sildenafil citrate Sildenafil citrate 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬50. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
51 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PDE5 [1] PDE5 💬cGMP-PKG signaling pathway
|
Sildenafil Sildenafil 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬50. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
52 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PDE5 [1] PDE5 💬cGMP-PKG signaling pathway
|
Tadalafil Tadalafil 💬cGMP-PKG signaling pathway
| Tadalafil | 006 [8] 6 , 51, 75, 77, 84, 86, 113, 210 💬52. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
53 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PDE5 [1] PDE5 💬cGMP-PKG signaling pathway
|
Udenafil Udenafil 💬cGMP-PKG signaling pathway
| Udenafil | 086 [2] 86, 210 💬
|
||||||||||||||||||||||||||||||||||||||||
54 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
ACE [1] ACE 💬Chagas disease
|
Enalapril maleate Enalapril maleate 💬Chagas disease
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬54. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||
55 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
ACE [1] ACE 💬Chagas disease
|
Enalapril Enalapril 💬Chagas disease
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬54. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||
56 | Chemical carcinogenesis - DNA adducts 💬 2 genes, 23 drugs (DrugBank) and 41 diseases |
PTGS2 [1] PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Aspirin Aspirin 💬Chemical carcinogenesis - DNA adducts
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬56. Chemical carcinogenesis - DNA adducts
|
||||||||||||||||||||||||||||||||||||||||
57 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Chemical carcinogenesis - receptor activation
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||
58 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Chemical carcinogenesis - receptor activation
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||
59 | Complement and coagulation cascades 💬 22 genes, 45 drugs (DrugBank) and 52 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 [6] 46, 49, 56, 91, 210, 271 💬59. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||
60 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
ACE [1] ACE 💬Coronavirus disease - COVID-19
|
Enalapril maleate Enalapril maleate 💬Coronavirus disease - COVID-19
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬60. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||
61 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
ACE [1] ACE 💬Coronavirus disease - COVID-19
|
Enalapril Enalapril 💬Coronavirus disease - COVID-19
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬60. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||
62 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
AGTR1 [1] AGTR1 💬Coronavirus disease - COVID-19
|
Valsartan Valsartan 💬Coronavirus disease - COVID-19
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬62. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||
63 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
AGTR1 [1] AGTR1 💬Cortisol synthesis and secretion
|
Valsartan Valsartan 💬Cortisol synthesis and secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬63. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||
64 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
AGTR1 [1] AGTR1 💬Cushing syndrome
|
Valsartan Valsartan 💬Cushing syndrome
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬64. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||
65 | Cytoskeleton in muscle cells 💬 26 genes, 19 drugs (DrugBank) and 14 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Cytoskeleton in muscle cells
| Digoxin | 008 [3] 8 , 46, 210 💬65. Cytoskeleton in muscle cells |
||||||||||||||||||||||||||||||||||||||||
66 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
ACE [1] ACE 💬Diabetic cardiomyopathy
|
Enalapril maleate Enalapril maleate 💬Diabetic cardiomyopathy
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬66. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
67 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
ACE [1] ACE 💬Diabetic cardiomyopathy
|
Enalapril Enalapril 💬Diabetic cardiomyopathy
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬66. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
68 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
AGTR1 [1] AGTR1 💬Diabetic cardiomyopathy
|
Valsartan Valsartan 💬Diabetic cardiomyopathy
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬68. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
69 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
ADRB1 [1] ADRB1 💬Dilated cardiomyopathy
|
Carvedilol Carvedilol 💬Dilated cardiomyopathy
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬69. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
70 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
ADRB1 [1] ADRB1 💬Dilated cardiomyopathy
|
Carvedilol phosphate Carvedilol phosphate 💬Dilated cardiomyopathy
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬69. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
71 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
PTGS2 [1] PTGS2 💬Efferocytosis
|
Aspirin Aspirin 💬Efferocytosis
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬71. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||
72 | Endocrine and other factor-regulated calcium reabsorption 💬 9 genes, 29 drugs (DrugBank) and 55 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Endocrine and other factor-regulated calcium reabsorption
| Digoxin | 008 [3] 8 , 46, 210 💬72. Endocrine and other factor-regulated calcium reabsorption |
||||||||||||||||||||||||||||||||||||||||
73 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
ADRB1 [1] ADRB1 💬Gap junction
|
Carvedilol Carvedilol 💬Gap junction
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬73. Gap junction
|
||||||||||||||||||||||||||||||||||||||||
74 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
ADRB1 [1] ADRB1 💬Gap junction
|
Carvedilol phosphate Carvedilol phosphate 💬Gap junction
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬73. Gap junction
|
||||||||||||||||||||||||||||||||||||||||
75 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Gap junction
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬75. Gap junction
|
||||||||||||||||||||||||||||||||||||||||
76 | Gastric acid secretion 💬 14 genes, 55 drugs (DrugBank) and 63 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Gastric acid secretion
| Digoxin | 008 [3] 8 , 46, 210 💬76. Gastric acid secretion |
||||||||||||||||||||||||||||||||||||||||
77 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
MME [1] MME 💬Hematopoietic cell lineage
|
Sacubitril Sacubitril 💬Hematopoietic cell lineage
| Sacubitril | 058 [3] 58, 210, 222 💬77. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||
78 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Hormone signaling
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬78. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||
79 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Hormone signaling
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬78. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||
80 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AGTR1 [1] AGTR1 💬Hormone signaling
|
Valsartan Valsartan 💬Hormone signaling
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬80. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||
81 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Hormone signaling
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||
82 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬82. Hormone signaling |
||||||||||||||||||||||||||||||||||||||||
83 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬82. Hormone signaling |
||||||||||||||||||||||||||||||||||||||||
84 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PTGS2 [1] PTGS2 💬Human cytomegalovirus infection
|
Aspirin Aspirin 💬Human cytomegalovirus infection
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬84. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||
85 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
PTGS2 [1] PTGS2 💬Human papillomavirus infection
|
Aspirin Aspirin 💬Human papillomavirus infection
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬85. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||
86 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Huntington disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬86. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||
87 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
ACE [1] ACE 💬Hypertrophic cardiomyopathy
|
Enalapril maleate Enalapril maleate 💬Hypertrophic cardiomyopathy
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬87. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
88 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
ACE [1] ACE 💬Hypertrophic cardiomyopathy
|
Enalapril Enalapril 💬Hypertrophic cardiomyopathy
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬87. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||
89 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
PTGS2 [1] PTGS2 💬IL-17 signaling pathway
|
Aspirin Aspirin 💬IL-17 signaling pathway
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬89. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
90 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Insulin secretion
| Digoxin | 008 [3] 8 , 46, 210 💬90. Insulin secretion |
||||||||||||||||||||||||||||||||||||||||
91 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PTGS2 [1] PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Aspirin Aspirin 💬Kaposi sarcoma-associated herpesvirus infection
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬91. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||
92 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
PTGS2 [1] PTGS2 💬Leishmaniasis
|
Aspirin Aspirin 💬Leishmaniasis
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬92. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||
93 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬93. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||
94 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬93. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||
95 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Macitentan Macitentan 💬Melanogenesis
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬95. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||
96 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
PTGS2 [1] PTGS2 💬MicroRNAs in cancer
|
Aspirin Aspirin 💬MicroRNAs in cancer
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬96. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||
97 | Mineral absorption 💬 10 genes, 14 drugs (DrugBank) and 41 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Mineral absorption
| Digoxin | 008 [3] 8 , 46, 210 💬97. Mineral absorption |
||||||||||||||||||||||||||||||||||||||||
98 | Motor proteins 💬 25 genes, 10 drugs (DrugBank) and 21 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Motor proteins
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬98. Motor proteins
|
||||||||||||||||||||||||||||||||||||||||
99 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Neuroactive ligand signaling
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬99. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||
100 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Neuroactive ligand signaling
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬99. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||
101 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Neuroactive ligand-receptor interaction
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬101. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
102 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Neuroactive ligand-receptor interaction
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬101. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
103 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AGTR1 [1] AGTR1 💬Neuroactive ligand-receptor interaction
|
Valsartan Valsartan 💬Neuroactive ligand-receptor interaction
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬103. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
104 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Neuroactive ligand-receptor interaction
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||
105 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [1] EDNRA 💬Neuroactive ligand-receptor interaction
|
Ambrisentan Ambrisentan 💬Neuroactive ligand-receptor interaction
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬105. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
106 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬106. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
107 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬106. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
108 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Neuroactive ligand-receptor interaction
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬108. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
109 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil Treprostinil 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬109. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
110 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬109. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
111 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil diolamine Treprostinil diolamine 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬109. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
112 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬112. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||||
113 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬112. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||||
114 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
PTGS2 [1] PTGS2 💬NF-kappa B signaling pathway
|
Aspirin Aspirin 💬NF-kappa B signaling pathway
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬114. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
115 | Ovarian steroidogenesis 💬 7 genes, 34 drugs (DrugBank) and 53 diseases |
PTGS2 [1] PTGS2 💬Ovarian steroidogenesis
|
Aspirin Aspirin 💬Ovarian steroidogenesis
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬115. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||
116 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
PTGS2 [1] PTGS2 💬Oxytocin signaling pathway
|
Aspirin Aspirin 💬Oxytocin signaling pathway
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬116. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
117 | Pancreatic secretion 💬 19 genes, 46 drugs (DrugBank) and 49 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Pancreatic secretion
| Digoxin | 008 [3] 8 , 46, 210 💬117. Pancreatic secretion |
||||||||||||||||||||||||||||||||||||||||
118 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Parkinson disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬118. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||||
119 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Pathogenic Escherichia coli infection
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬119. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||
120 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
AGTR1 [1] AGTR1 💬Pathways in cancer
|
Valsartan Valsartan 💬Pathways in cancer
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬120. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
121 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [1] EDNRA 💬Pathways in cancer
|
Ambrisentan Ambrisentan 💬Pathways in cancer
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬121. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
122 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬122. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
123 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬122. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
124 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Pathways in cancer
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬124. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
125 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
PTGS2 [1] PTGS2 💬Pathways in cancer
|
Aspirin Aspirin 💬Pathways in cancer
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬125. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
126 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
PTGS2 [1] PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Aspirin Aspirin 💬Pathways of neurodegeneration - multiple diseases
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬126. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||
127 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Pathways of neurodegeneration - multiple diseases
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬127. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||
128 | Phagosome 💬 37 genes, 16 drugs (DrugBank) and 30 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Phagosome
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬128. Phagosome
|
||||||||||||||||||||||||||||||||||||||||
129 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AGTR1 [1] AGTR1 💬Phospholipase D signaling pathway
|
Valsartan Valsartan 💬Phospholipase D signaling pathway
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬129. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
130 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Phospholipase D signaling pathway
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||
131 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil Treprostinil 💬Platelet activation
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬131. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||
132 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Platelet activation
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬131. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||
133 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil diolamine Treprostinil diolamine 💬Platelet activation
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬131. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||
134 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGS1 [1] PTGS1 💬Platelet activation
|
Aspirin Aspirin 💬Platelet activation
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬134. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||
135 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Prion disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬135. Prion disease
|
||||||||||||||||||||||||||||||||||||||||
136 | Protein digestion and absorption 💬 15 genes, 13 drugs (DrugBank) and 16 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Protein digestion and absorption
| Digoxin | 008 [3] 8 , 46, 210 💬136. Protein digestion and absorption |
||||||||||||||||||||||||||||||||||||||||
137 | Protein digestion and absorption 💬 15 genes, 13 drugs (DrugBank) and 16 diseases |
MME [1] MME 💬Protein digestion and absorption
|
Sacubitril Sacubitril 💬Protein digestion and absorption
| Sacubitril | 058 [3] 58, 210, 222 💬137. Protein digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||
138 | Proximal tubule bicarbonate reclamation 💬 7 genes, 7 drugs (DrugBank) and 16 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Proximal tubule bicarbonate reclamation
| Digoxin | 008 [3] 8 , 46, 210 💬138. Proximal tubule bicarbonate reclamation |
||||||||||||||||||||||||||||||||||||||||
139 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
PDE5 [1] PDE5 💬Purine metabolism
|
Sildenafil citrate Sildenafil citrate 💬Purine metabolism
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬139. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||
140 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
PDE5 [1] PDE5 💬Purine metabolism
|
Sildenafil Sildenafil 💬Purine metabolism
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬139. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||
141 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
PDE5 [1] PDE5 💬Purine metabolism
|
Tadalafil Tadalafil 💬Purine metabolism
| Tadalafil | 006 [8] 6 , 51, 75, 77, 84, 86, 113, 210 💬141. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||
142 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
PDE5 [1] PDE5 💬Purine metabolism
|
Udenafil Udenafil 💬Purine metabolism
| Udenafil | 086 [2] 86, 210 💬
|
||||||||||||||||||||||||||||||||||||||||
143 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Regulation of lipolysis in adipocytes
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬143. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||
144 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Regulation of lipolysis in adipocytes
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬143. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||
145 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
PTGS1 [2] PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Regulation of lipolysis in adipocytes
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬145. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||
146 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬146. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
147 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬146. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
148 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Macitentan Macitentan 💬Relaxin signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬148. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
149 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ACE [1] ACE 💬Renin secretion
|
Enalapril maleate Enalapril maleate 💬Renin secretion
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬149. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
150 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ACE [1] ACE 💬Renin secretion
|
Enalapril Enalapril 💬Renin secretion
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬149. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
151 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Renin secretion
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬151. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
152 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Renin secretion
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬151. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
153 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
AGTR1 [1] AGTR1 💬Renin secretion
|
Valsartan Valsartan 💬Renin secretion
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬153. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
154 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Ambrisentan Ambrisentan 💬Renin secretion
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬154. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
155 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬155. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
156 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬155. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
157 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Macitentan Macitentan 💬Renin secretion
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬157. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||
158 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
ACE [1] ACE 💬Renin-angiotensin system
|
Enalapril maleate Enalapril maleate 💬Renin-angiotensin system
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬158. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||
159 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
ACE [1] ACE 💬Renin-angiotensin system
|
Enalapril Enalapril 💬Renin-angiotensin system
| Enalapril | 013 [8] 13, 19, 46, 66, 113, 210, 222, 279 💬158. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||
160 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
AGTR1 [1] AGTR1 💬Renin-angiotensin system
|
Valsartan Valsartan 💬Renin-angiotensin system
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬160. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||
161 | Renin-angiotensin system 💬 6 genes, 21 drugs (DrugBank) and 32 diseases |
MME [1] MME 💬Renin-angiotensin system
|
Sacubitril Sacubitril 💬Renin-angiotensin system
| Sacubitril | 058 [3] 58, 210, 222 💬161. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||
162 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
PTGS2 [1] PTGS2 💬Retrograde endocannabinoid signaling
|
Aspirin Aspirin 💬Retrograde endocannabinoid signaling
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬162. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||
163 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Salivary secretion
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬163. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||
164 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Salivary secretion
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬163. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||
165 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Salivary secretion
| Digoxin | 008 [3] 8 , 46, 210 💬165. Salivary secretion |
||||||||||||||||||||||||||||||||||||||||
166 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
TUBB [9] TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Salmonella infection
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬166. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||
167 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
PTGS1 [2] PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Serotonergic synapse
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬167. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||
168 | Small cell lung cancer 💬 16 genes, 43 drugs (DrugBank) and 64 diseases |
PTGS2 [1] PTGS2 💬Small cell lung cancer
|
Aspirin Aspirin 💬Small cell lung cancer
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬168. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||
169 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin sodium Pravastatin sodium 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 [10] 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬169. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||
170 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin Pravastatin 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 [10] 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬169. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||
171 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Thyroid hormone signaling pathway
| Digoxin | 008 [3] 8 , 46, 210 💬171. Thyroid hormone signaling pathway |
||||||||||||||||||||||||||||||||||||||||
172 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬172. Thyroid hormone signaling pathway |
||||||||||||||||||||||||||||||||||||||||
173 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬172. Thyroid hormone signaling pathway |
||||||||||||||||||||||||||||||||||||||||
174 | Thyroid hormone synthesis 💬 7 genes, 10 drugs (DrugBank) and 7 diseases |
ATP1A [4] ATP1A, ATP1A, ATP1A, ATP1A 💬
|
Digoxin Digoxin 💬Thyroid hormone synthesis
| Digoxin | 008 [3] 8 , 46, 210 💬174. Thyroid hormone synthesis |
||||||||||||||||||||||||||||||||||||||||
175 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
PTGS2 [1] PTGS2 💬TNF signaling pathway
|
Aspirin Aspirin 💬TNF signaling pathway
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬175. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
176 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬
|
Carvedilol Carvedilol 💬Vascular smooth muscle contraction
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬176. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
177 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Vascular smooth muscle contraction
| Carvedilol | 006 [6] 6 , 46, 57, 86, 113, 210 💬176. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
178 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AGTR1 [1] AGTR1 💬Vascular smooth muscle contraction
|
Valsartan Valsartan 💬Vascular smooth muscle contraction
| Valsartan | 057 [8] 57, 58, 66, 75, 86, 210, 222, 224 💬178. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
179 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
AVPR1A [2] AVPR1A, AVPR1B 💬
|
Vasopressin Vasopressin 💬Vascular smooth muscle contraction
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||
180 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Ambrisentan Ambrisentan 💬Vascular smooth muscle contraction
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬180. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
181 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬181. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
182 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬181. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
183 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Macitentan Macitentan 💬Vascular smooth muscle contraction
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬183. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
184 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil Treprostinil 💬Vascular smooth muscle contraction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬184. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
185 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Vascular smooth muscle contraction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬184. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
186 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil diolamine Treprostinil diolamine 💬Vascular smooth muscle contraction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬184. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||
187 | Vasopressin-regulated water reabsorption 💬 1 gene, 5 drugs (DrugBank) and 10 diseases |
AVPR2 [1] AVPR2 💬Vasopressin-regulated water reabsorption
|
Vasopressin Vasopressin 💬Vasopressin-regulated water reabsorption
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||
188 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PTGS2 [1] PTGS2 💬VEGF signaling pathway
|
Aspirin Aspirin 💬VEGF signaling pathway
| Acetylsalicylic acid | 013 [15] 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬188. VEGF signaling pathway
|
Adrenergic signaling in cardiomyocytes
31 genes, 84 drugs (DrugBank) and 76 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Aldosterone synthesis and secretion
20 genes, 41 drugs (DrugBank) and 61 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 30 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
AMPK signaling pathway
16 genes, 56 drugs (DrugBank) and 95 diseases
Amyotrophic lateral sclerosis
38 genes, 55 drugs (DrugBank) and 109 diseases
Apelin signaling pathway
20 genes, 36 drugs (DrugBank) and 77 diseases
Arachidonic acid metabolism
5 genes, 25 drugs (DrugBank) and 44 diseases
Bile secretion
14 genes, 36 drugs (DrugBank) and 61 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Carbohydrate digestion and absorption
13 genes, 21 drugs (DrugBank) and 33 diseases
Cardiac muscle contraction
17 genes, 20 drugs (DrugBank) and 25 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Chemical carcinogenesis - DNA adducts
2 genes, 23 drugs (DrugBank) and 41 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Complement and coagulation cascades
22 genes, 45 drugs (DrugBank) and 52 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cortisol synthesis and secretion
15 genes, 36 drugs (DrugBank) and 63 diseases
Cushing syndrome
24 genes, 55 drugs (DrugBank) and 71 diseases
Cytoskeleton in muscle cells
26 genes, 19 drugs (DrugBank) and 14 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Dilated cardiomyopathy
24 genes, 61 drugs (DrugBank) and 88 diseases
Efferocytosis
29 genes, 74 drugs (DrugBank) and 93 diseases
Endocrine and other factor-regulated calcium reabsorption
9 genes, 29 drugs (DrugBank) and 55 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Gastric acid secretion
14 genes, 55 drugs (DrugBank) and 63 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Huntington disease
26 genes, 39 drugs (DrugBank) and 87 diseases
Hypertrophic cardiomyopathy
27 genes, 57 drugs (DrugBank) and 90 diseases
IL-17 signaling pathway
20 genes, 61 drugs (DrugBank) and 86 diseases
Insulin secretion
15 genes, 48 drugs (DrugBank) and 51 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
Melanogenesis
7 genes, 19 drugs (DrugBank) and 34 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
Mineral absorption
10 genes, 14 drugs (DrugBank) and 41 diseases
Motor proteins
25 genes, 10 drugs (DrugBank) and 21 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
NF-kappa B signaling pathway
22 genes, 77 drugs (DrugBank) and 91 diseases
Ovarian steroidogenesis
7 genes, 34 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Pancreatic secretion
19 genes, 46 drugs (DrugBank) and 49 diseases
Parkinson disease
24 genes, 76 drugs (DrugBank) and 68 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Phagosome
37 genes, 16 drugs (DrugBank) and 30 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
Platelet activation
25 genes, 67 drugs (DrugBank) and 64 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Protein digestion and absorption
15 genes, 13 drugs (DrugBank) and 16 diseases
Proximal tubule bicarbonate reclamation
7 genes, 7 drugs (DrugBank) and 16 diseases
Purine metabolism
30 genes, 40 drugs (DrugBank) and 73 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 79 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Renin-angiotensin system
6 genes, 21 drugs (DrugBank) and 32 diseases
Retrograde endocannabinoid signaling
34 genes, 65 drugs (DrugBank) and 68 diseases
Salivary secretion
21 genes, 74 drugs (DrugBank) and 72 diseases
Salmonella infection
30 genes, 46 drugs (DrugBank) and 75 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Small cell lung cancer
16 genes, 43 drugs (DrugBank) and 64 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 56 diseases
Thyroid hormone signaling pathway
25 genes, 45 drugs (DrugBank) and 73 diseases
Thyroid hormone synthesis
7 genes, 10 drugs (DrugBank) and 7 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
Vascular smooth muscle contraction
32 genes, 92 drugs (DrugBank) and 71 diseases
Vasopressin-regulated water reabsorption
1 gene, 5 drugs (DrugBank) and 10 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases